Short term memory loss and alzheimer's
Pro Research Analysisby 
Searched over 200M research papers
Short-Term Memory Loss and Alzheimer's Disease
Introduction to Alzheimer's Disease and Memory Impairment
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline, with memory loss being one of the earliest and most prominent symptoms. Both short-term and long-term memory are affected as the disease progresses, leading to significant impairments in daily functioning1 7.
Short-Term Memory Deficits in Alzheimer's Disease
Role of the Hippocampus
The hippocampus plays a crucial role in memory formation and retrieval. In Alzheimer's disease, pathological changes are particularly evident in the hippocampal region, leading to severe impairments in short-term memory. This damage disrupts the ability to retain new information temporarily and affects the establishment of long-term memories1 5.
Visual Short-Term Memory Binding
Recent studies have highlighted deficits in visual short-term memory binding in individuals with familial Alzheimer's disease. This impairment involves difficulties in retaining complex visual information, such as shapes and colors, and is detectable even in asymptomatic carriers of the disease-causing mutations. These findings suggest that visual short-term memory binding deficits could serve as early markers for Alzheimer's disease2 4.
Phonological Short-Term Memory
In cases of primary progressive aphasia, particularly the logopenic variant, there is a notable decline in phonological short-term memory. This subtype of Alzheimer's disease presents with language impairments and progressive memory loss, further complicating the clinical picture and diagnosis6.
Biochemical and Genetic Factors
Cholinergic Dysfunction
The cholinergic system, particularly the neurotransmitter acetylcholine, is significantly affected in Alzheimer's disease. The enzyme choline acetyltransferase, which is essential for acetylcholine synthesis, is depleted in the hippocampus. This depletion is believed to contribute to the short-term memory deficits observed in Alzheimer's patients. Pharmacological interventions targeting this pathway may offer potential therapeutic benefits5.
Blood Biomarkers
Research has identified several blood biomarkers associated with short-term memory dysfunction in Alzheimer's disease. These biomarkers, including genes like RAB7A, NPC2, and TGFB1, have shown promise in predicting cognitive impairment and may aid in early diagnosis and personalized treatment strategies8.
Clinical Implications and Diagnostic Approaches
Neuropsychological Testing
Despite advances in biomarker research, neuropsychological testing remains a cornerstone in the diagnosis of Alzheimer's disease. Tests assessing working memory, long-term declarative memory, and other cognitive functions are crucial for identifying the extent and pattern of memory impairment, which can help in disease grading and prognostic predictions7.
Imaging and Biomarkers
Imaging studies, such as MRI and PET scans, along with cerebrospinal fluid analysis, provide valuable insights into the structural and biochemical changes in the brain. These tools, combined with neuropsychological assessments, enhance the accuracy of Alzheimer's disease diagnosis and help in identifying atypical presentations, such as early-onset cases with non-fluent aphasia3 7.
Conclusion
Short-term memory loss is a hallmark of Alzheimer's disease, driven by hippocampal damage and cholinergic dysfunction. Advances in understanding visual and phonological short-term memory deficits, along with the identification of blood biomarkers, offer promising avenues for early detection and intervention. Continued research into the biochemical and genetic underpinnings of memory impairment in Alzheimer's disease is essential for developing effective diagnostic and therapeutic strategies.
Sources and full results
Most relevant research papers on this topic
Short- and long-term memory in patients with presenile dementia (Alzheimer's disease)
Alzheimer's disease patients experience impairments in short-term memory and difficulty establishing new material in long-term storage, with the two types of memory disorders being qualitatively different.
Highly CitedVisual short-term memory binding deficits in familial Alzheimer's disease.
Visual short-term memory binding deficits may be a preclinical marker for familial Alzheimer's disease, as they are more sensitive and specific than other neuropsychological measures.
Observational Study
Rigorous JournalHighly CitedCase of early-onset Alzheimer’s disease with atypical manifestation
Early-onset Alzheimer's disease may have progressive non-fluent aphasia as its core manifestation, and individual and precision diagnosis is crucial for accurate diagnosis and treatment.
Case ReportRigorous JournalVisual short-term memory binding deficit in familial Alzheimer's disease
Familial Alzheimer's disease (FAD) mutation carriers show greater object-location binding deficits, which may serve as a sensitive cognitive biomarker for medial temporal lobe dysfunction in various diseases.
Non-RCT
Very Rigorous JournalHighly CitedPossible biochemical basis of memory disorder in Alzheimer disease
Alzheimer's disease may be improved by pharmacological means by targeting a cholinergic neuronal pathway in the hippocampus.
Highly CitedLongitudinal assessment of short-term memory deterioration in a logopenic variant primary progressive aphasia with post-mortem confirmed Alzheimer's Disease pathology.
Logopenic variant primary progressive aphasia (PPA-LV) is an atypical presentation of Alzheimer's disease, with phonological short-term memory deterioration over time.
Case ReportMemory loss in Alzheimer's disease
Memory loss in Alzheimer's disease is a key symptom and correlates with brain integrity, aiding in diagnosis and understanding the disease's impact.
Highly CitedBlood biomarkers for memory: toward early detection of risk for Alzheimer disease, pharmacogenomics, and repurposed drugs
Blood biomarkers identified in this study can help predict short-term memory dysfunction in psychiatric patients, potentially aiding in early detection and personalized treatment.
Observational StudyVery Rigorous JournalModeling the Role of the Glymphatic Pathway and Cerebral Blood Vessel Properties in Alzheimer’s Disease Pathogenesis
Vessel stiffness and heart rate play a crucial role in maintaining adequate clearance of beta amyloid from the brain, which is crucial for Alzheimer's disease pathogenesis.
Rigorous JournalHighly CitedPathways towards and away from Alzheimer's disease
Understanding the cellular and molecular alterations responsible for Alzheimer's disease may lead to effective preventative and therapeutic strategies.
Highly Cited